H2020HORIZONFP7
Stichting Amsterdam Umc
- Country
- NLNetherlands
- Defence projects
- 0
- Projects, all programmes
- 311
- As coordinator
- 104
- EU contribution (CORDIS)
- EUR 206,250,417
- Active
- 2011 to 2026
Projects
311 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| VEOVersatile Emerging infectious disease Observatory | H2020 | 2020 | Participant | EUR 390,575 |
| CAPABLECAncer PAtients Better Life Experience | H2020 | 2020 | Participant | EUR 469,925 |
| STIMULUSStimuli Responsive Materials for the Rapid Detection and Treatment of Healthcare Associated Infections | H2020 | 2020 | Participant | EUR 531,240 |
| QUALITOPMonitoring multidimensional aspects of QUAlity of Life after cancer ImmunoTherapy - an Open smart digital Platform for personalized prevention and patient management | H2020 | 2020 | Participant | EUR 356,558 |
| MIMMolecular Imaging of Microglia | H2020 | 2020 | Coordinator | EUR 175,572 |
| HARMONY PLUSHEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS | H2020 | 2020 | Participant | EUR 90,000 |
| ImpentriDevelopment of Impentri, an intravenous imatinib formulation for Covid-19 acute respiratory distress syndrome (ARDS). | H2020 | 2020 | Participant | EUR 1,091,880 |
| MATCHDiscovering a novel allergen immunotherapy in house dust mite allergy tolerance research | H2020 | 2020 | Coordinator | EUR 150,000 |
| RISCCRISK-BASED SCREENING FOR CERVICAL CANCER | H2020 | 2020 | Coordinator | EUR 1,584,872 |
| HumanNeuronScreenDrug discovery screening using human neurons | H2020 | 2020 | Coordinator | EUR 150,000 |
| EDUC8Early Stage Researchers EDUCational Program on Factor VIII Immunogenicity | H2020 | 2020 | Participant | EUR 265,620 |
| AFFECT-EUDIGITAL, RISK-BASED SCREENING FOR ATRIAL FIBRILLATION IN THE EUROPEAN COMMUNITY | H2020 | 2020 | Participant | EUR 90,000 |
| CEMBOExcellence in the research area of Combating and evaluation of mixed biofilms. | H2020 | 2020 | Participant | EUR 280,923 |
| UNPACK PD-L1Molecular mechanism and inhibition of extracellular vesicle-mediated PD-L1 release in melanoma cells | H2020 | 2020 | Coordinator | EUR 175,572 |
| FAIRFLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIA | H2020 | 2020 | Participant | EUR 1,251,170 |
| SkinTERMSkin Tissue Engineering and Regenerative Medicine: From skin repair to regeneration | H2020 | 2020 | Participant | EUR 265,620 |
| AngioCARChimeric antigen receptor (CAR) T-cell therapy against solid tumors by targeting the vasculature | H2020 | 2020 | Coordinator | EUR 175,572 |
| ImmunoSepPersonalized immunotherapy in sepsis: a precision medicine based approach | H2020 | 2020 | Participant | EUR 900,087 |
| ImmUniverseBetter control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies | H2020 | 2020 | Participant | EUR 633,048 |
| RECOGNISEDRetinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia | H2020 | 2020 | Participant | EUR 450,000 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.